GS-441524 Treatment for FIP: What It Is and Why It Works

Hearing that your cat has Feline Infectious Peritonitis (FIP) can still feel like the floor has dropped out from under you. For decades, this diagnosis was considered fatal. That reality has changed. Today, cats across the UAE, Saudi Arabia, and Qatar are recovering from FIP because of one molecule: GS-441524.

GS-441524 Treatment for FIP: What It Is and Why It Works

This is the foundational guide to GS-441524 treatment. We will explain what the compound is, how it works inside your cat's body, what the research says about its commonly reported success rate, and how CureFIP GCC delivers it to cat parents across the Gulf.

What Is GS-441524?

GS-441524 is a nucleoside analog antiviral. In plain language, it is a small molecule that looks almost identical to one of the natural building blocks the FIP virus needs to copy itself. When the virus tries to use GS-441524 instead of the real building block, the copying process stops. The virus cannot replicate, and the infection begins to lose ground.

GS-441524 is the parent compound of remdesivir, a drug many people became familiar with during the COVID-19 pandemic. For cats, GS-441524 is the active antiviral that has reshaped FIP outcomes since 2019.

A few important facts:

1. GS-441524 is feline-specific in its clinical use. It was studied for FIP at UC Davis under Dr. Niels Pedersen.

2. It works against Feline Coronavirus (FCoV), the virus that mutates inside the cat to cause FIP.

3. It does not suppress the immune system. It targets the virus directly, allowing the cat's own immunity to recover.

Why FIP Needed a New Kind of Drug

FIP develops when a common gut virus, FCoV, mutates inside an individual cat and begins infecting macrophages, a type of immune cell. From there it spreads through the body, triggering inflammation in the abdomen, chest, eyes, or brain.

Before GS-441524, treatment options were limited to steroids and supportive care. These could ease symptoms for a short time but did nothing to stop viral replication. FIP was once a death sentence for cats. The breakthrough was finding a molecule that could cross into the cells where the virus hides and shut down its replication machinery. GS-441524 does exactly that.

The UC Davis Research: Where the 92% Number Comes From

The most cited evidence behind GS-441524 treatment comes from the UC Davis clinical work published by Pedersen and colleagues in 2019 (PMC6435921). In that study, cats with naturally occurring FIP were treated with subcutaneous GS-441524 injections over a 12 week course.

The commonly reported success rate from that body of research is up to 92%. Here is the science behind that statement: cats received daily injections, were monitored for clinical signs and bloodwork changes, and were followed for relapse after the 84 day protocol ended. The majority achieved sustained remission.

A few things to keep in mind when you read that figure:

1. The 92% success rate applies to GS-441524 monotherapy delivered as injectables, not to every protocol on the market.

2. Dosing was matched to the form of FIP, with higher milligrams per kilogram for cases involving the eyes or central nervous system.

3. Early, consistent treatment was a recurring factor in successful outcomes.

Higher milligrams of GS-441524 do not equal better FIP protection. The correct dose for the correct form of disease is what matters.

The Four Forms of FIP and Why Dosing Differs

GS-441524 reaches different tissues at different concentrations. That is why veterinarians match the dose to where the virus is doing the most damage. There are four forms of FIP, and each has its own dosing target.

1. Wet (Effusive) FIP

Fluid accumulates in the abdomen or chest. This is often the form cat parents notice first because of a visibly swollen belly or labored breathing. Wet FIP responds well to GS-441524 because the drug distributes readily through the bloodstream and into effusions.

2. Dry (Non-Effusive) FIP

No significant fluid, but granulomas form in organs such as the liver, kidneys, lymph nodes, or intestines. Symptoms are vaguer: weight loss, fever that does not respond to antibiotics, jaundice, lethargy. Dry FIP usually requires a slightly higher dose than wet FIP to penetrate solid tissue lesions.

3. Ocular FIP

The eyes are involved, with signs such as color change in the iris, cloudiness, uveitis, or sudden vision loss. The blood-eye barrier limits drug entry, so ocular FIP requires a higher GS-441524 dose to reach therapeutic concentrations inside the eye.

4. Neurological FIP

The central nervous system is affected. Signs include wobbliness, seizures, behavioral changes, head tilt, or hind limb weakness. The blood-brain barrier is the toughest obstacle for any antiviral, which is why neurological FIP requires the highest GS-441524 dose of all four forms.

Matching the dose to the form is one of the reasons trained veterinary supervision is essential throughout the 12 week protocol.

How GS-441524 Treatment Works Day to Day

The standard GS-441524 injectable protocol is straightforward in structure, even if it asks a lot from cat parents emotionally and logistically.

1. One subcutaneous injection per day, 7 days per week.

2. Duration of 12 weeks, which equals 84 consecutive days.

3. Dose calculated by current body weight and form of FIP: wet 6 mg/kg, dry 8 mg/kg, ocular 10 mg/kg, neurological 10 mg/kg.

4. Weight is rechecked regularly because most cats gain weight as they recover, and the dose is adjusted upward to match.

5. Bloodwork is monitored to track A:G ratio, globulins, ALT, SDMA, and hematocrit.

After the 84 day course, an observation period of around 12 weeks follows. If bloodwork stays stable and clinical signs do not return, the cat is considered in sustained remission.

The CureFIP GCC Product Range

CureFIP GCC provides GS-441524 in three injectable concentrations, plus a dual antiviral oral option for cases where injections are not the right fit. All prices are listed in AED exactly as on the live store.

GS-441524 Antiviral Injectables, 20 mg/ml, AED359.00

A lower concentration suited to smaller cats and lower dose protocols. Dosing follows the standard guide: wet 6 mg/kg, dry 8 mg/kg, ocular 10 mg/kg, neurological 10 mg/kg, one subcutaneous injection per day for 12 weeks (84 days). Reference: Pedersen et al., UC Davis (PMC6435921).

GS-441524 Antiviral Injectables, 30mg/ml 10ML, AED479.00

A mid-strength option that suits a wide range of body weights and FIP forms. Same daily schedule and 12 week duration.

GS-441524 Antiviral Injectables, 40 mg/ml, AED599.00

A higher concentration that reduces injection volume, often preferred for larger cats or higher dose cases such as ocular and neurological FIP. Same daily schedule and 12 week duration.

CURE FIP™ Dual Antiviral Oral Capsules (GS-441524 + EIDD-1931), AED499.00

For cat parents who cannot manage daily injections, an oral combination is available. Dosing is by weight band: under 2.5 kg uses GS-441524 25 mg plus EIDD-1931 5 mg, 2.5 to 5 kg uses GS-441524 35 mg plus EIDD-1931 8 mg, and over 5 kg uses GS-441524 50 mg plus EIDD-1931 12 mg. One capsule per day, every day, for a recommended 12 weeks.

A note on efficacy: the commonly reported 92% success rate refers specifically to GS-441524 injectable monotherapy as studied by UC Davis. The dual antiviral oral route (GS-441524 plus EIDD-1931) is supported by separate research from Li and Cheah (2025), which reports a 78.3% remission figure. These are different protocols with different evidence bases, and they should not be averaged or interchanged.

The oral dual route is positioned for wet and dry FIP. In some regions it is not recommended once ocular or neurological signs are present, or when the cat cannot eat or defecate normally. For those cases, injectables remain the protocol of choice.

100,000+ Cats and Counting

Since 2019, more than 100,000 cats have been treated with GS-441524 across the global network. That number represents an enormous body of real-world experience that goes beyond the original clinical trial. It includes slow responders, relapse cases, kittens, senior cats, and cats with concurrent conditions. The pattern that holds across all of them is the same: early detection plus a complete 84 day protocol, with proper dosing and veterinary supervision, gives cats the strongest chance of recovery.

Supportive Care During the 12 Week Protocol

GS-441524 does the antiviral work, but recovery is a whole-body process. Many veterinarians recommend supportive care alongside treatment:

1. High calorie, palatable nutrition to rebuild lost weight.

2. Hydration support, especially in the first two weeks.

3. Quiet, low-stress housing while inflammation subsides.

4. Optional organ support such as LiverRx™ if bloodwork shows elevated ALT, used only as an adjunct and never as a replacement for antiviral therapy.

5. Regular weight checks and bloodwork at weeks 4, 8, and 12.

These steps do not replace GS-441524. They support the cat while the antiviral does its job.

What to Expect Week by Week

A general week-by-week pattern looks like this:

1. Week 1 to 2: fever often breaks within 24 to 72 hours. Appetite begins to return. Effusions start to reduce in wet cases.

2. Week 3 to 6: weight gain becomes visible. Bloodwork begins normalizing, with A:G ratio improving and globulins falling.

3. Week 7 to 10: most cats look clinically well. Doses are recalculated to current body weight.

4. Week 11 to 12: final stretch of the 84 day protocol. Do not stop early even if the cat looks fully recovered, because incomplete courses are a common cause of relapse.

Slow responders exist. Some cats need dose increases, extended protocols, or a switch to a different concentration. This is one of the reasons veterinary supervision throughout the 12 weeks is essential.

FAQ

Is GS-441524 safe for cats?

GS-441524 has been used in more than 100,000 cats since 2019. Commonly reported side effects include injection site discomfort with the subcutaneous route. Veterinary supervision is essential, and bloodwork should be monitored throughout the 12 week protocol.

How quickly will I see improvement after starting GS-441524 treatment?

Many cats show a drop in fever within 24 to 72 hours and improved appetite in the first week. Visible weight gain and bloodwork improvement typically follow over the next several weeks. Recovery is a gradual, week-by-week process.

Can I stop treatment early if my cat looks better?

No. The full 84 day protocol is essential, even when your cat appears clinically well. Stopping early is one of the most common causes of relapse. Always complete the 12 weeks under veterinary supervision.

What is the difference between GS-441524 injectables and the dual antiviral capsules?

The injectables deliver GS-441524 as monotherapy, supported by the UC Davis research with a commonly reported 92% success rate. The CURE FIP™ Dual Antiviral Oral Capsules combine GS-441524 with EIDD-1931 and are supported by Li and Cheah (2025), which reports 78.3% remission. The oral route is positioned for wet and dry FIP and is not recommended for ocular or neurological cases.

Where can I get GS-441524 treatment in the GCC?

CureFIP GCC ships GS-441524 injectables and CURE FIP™ dual antiviral capsules across the UAE, Saudi Arabia, and Qatar. Visit curefipgcc.com to view the full product range and reach the support team for protocol guidance.